CN Stock MarketDetailed Quotes

300199 Hybio Pharmaceutical

Watchlist
  • 11.58
  • +0.02+0.17%
Noon Break Nov 18 11:30 CST
10.23BMarket Cap-27769P/E (TTM)

About Hybio Pharmaceutical Company

The company was founded in April 2003 and is a national high-tech enterprise specializing in research, production and marketing of peptide drugs. The company was listed on the Shenzhen Stock Exchange in 2011 and is the earliest listed peptide pharmaceutical company in China. The company's main business is the production and sale of peptide APIs. The company's main products include peptide preparations, peptide raw materials, customer-specific peptides, cosmetic peptides, solid pharmaceutical preparations, medical devices, peptide skin care products, health products, etc. Company Honors: National High-tech Enterprise, National Advanced Technology Industrialization Demonstration Project, 2010 China's Top 200 Potential Enterprises, etc.

Company Profile

Short Name-A翰宇药业
Symbol-A300199
Listing DateApr 7, 2011
Issue Price30.19
Shares Offered25.00M share(s)
FoundedApr 2, 2003
Legal Representativeshaogui ceng
Secretarydi yang
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativepingping li
Legal CounselGuo Hao Law Firm (Shenzhen)
Employees429
Phone0755-26588036
Office AddressHanyu Innovation Industrial Building, No. 7, Guansheng 4th Road, Guanlan High-tech Park, Longhua District, Shenzhen
Zip Code518110
Registered AddressHanyu Innovation Industrial Building, No. 7 Guansheng 4th Road, Guanlan High-tech Park, Longhua District, Shenzhen, Guangdong
Fax0755-26588022
Emailhy@hybio.com.cn
Business License440301103008894
BusinessProduction and operation of tablets, hard capsules, granules, small-volume injections, freeze-dried powder injections, APIs (produced according to the types approved by the Pharmaceutical Production License), import and export business; non-residential real estate leasing; medical research and experimental development; technical services, technology development, technical consultation, technology exchange, technology transfer, and technology promotion.

Company Executives

  • Name
  • Position
  • Salary
  • shaogui ceng
  • Chairman, Directors, Strategy Committee Convener
  • --
  • shaoqiang ceng
  • Vice Chairman, Directors, Nomination Committee Members, Strategy Committee Member
  • --
  • pinxiang yu
  • Directors, Executive President, Strategy Committee Member
  • 1.95M
  • yangming tang
  • Directors, VP
  • 976.90K
  • shaobin ceng
  • Directors, Strategy Committee Member, Audit Committee Member
  • 65.70K
  • di yang
  • Directors, Board Secretary, VP, Member of the Remuneration and Assessment Committee
  • 781.00K
  • zhihong kang
  • Independent Directors, Member of the Remuneration and Assessment Committee, Audit Committee Convener
  • 75.50K
  • wenyan hu
  • Independent Directors, Audit Committee Member, Nomination Committee Convener
  • 120.00K
  • lian zhong
  • Independent Directors, Nomination Committee Members, Strategy Committee Member, Remuneration and Assessment Committee Convener
  • 60.00K
  • pingping li
  • Securities Affairs Representative
  • --
  • qingyang li
  • Chairman of the Supervisory Board, Auditors
  • 464.60K
  • lu yang
  • Auditors, Head of Internal Audit
  • 388.00K
  • baole zhang
  • VP
  • --
  • min zhang
  • VP
  • 616.50K
  • honghong tu
  • VP, Chief Financial Officer
  • 649.80K
  • lin liang
  • Employee Supervisors
  • 345.30K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data